Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life.
- Celon Pharma S.A. at the Jefferies Healthcare Conference 2021.Representatives of the Management Board of Celon Pharma S.A. will take part in the 12th edition of the largest European conference on life science.
- Doubled export sales, continuation of the strategy of investing in research and developmentNet revenue from total sales in the first half of 2021 totalled PLN 105 million. Mostly due to export sales, which exceeded domestic sales. The majority of the Company's products have maintained their market share in Poland, while the dynamic of the entire drug market in Poland has been decreasing.
- Current report 42/2021 – Registration of D-series shares with the KDPWThe Management Board of Celon Pharma S.A. (the “Company”) hereby announces that it was informed of the publication of an announcement by Krajowy Depozyt Papierów Wartościowych S.A. on the registration in the securities depository of 6,000,000 of the Company's ordinary D-series bearer shares under ISIN PLCLNPH00015 code on September 22, 2021
Research and development
We create innovative drugs, that will change the lives of patients globally
We are leaders in